CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-06 | Mendez Manuel O. SVP & Chief Commercial Officer | Shares withheld for taxes | −5,871 | $114.01 | $669K | 23,982 |
| 2020-10-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +270 | $114.01 | $31K | 10,005.11 |
| 2020-09-02 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Option exercise | +58,392 | $66.51 | $3.9M | 126,803 |
| 2020-09-02 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −54,616 | $110.57 | $6.0M | 72,187 |
| 2020-09-02 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −3,776 | $111.13 | $420K | 68,411 |
| 2020-09-02 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Option exercise · Non-Qualifed Stock Option (right to buy) | −58,392 | $66.51 | $3.9M | 0 |
| 2011-01-31 | GLAXOSMITHKLINE PLC Director | Sale | −15,377,600 | $55.62 | $855.2M | 15,377,551 |
| 2011-01-31 | GLAXOSMITHKLINE PLC Director | Sale | −15,377,551 | $54.30 | $835.0M | 0 |
| 2009-03-19 | GLAXOSMITHKLINE PLC Director | Sale | −230,295 | $44.36 | $10.2M | 35,274,013 |
| 2009-03-19 | GLAXOSMITHKLINE PLC Director | Sale | −7,205 | $45.24 | $326K | 35,266,808 |
| 2009-03-19 | GLAXOSMITHKLINE PLC Director | Sale | −4,511,657 | $44.33 | $200.0M | 30,755,151 |
| 2009-03-18 | GLAXOSMITHKLINE PLC Director | Sale | −478,899 | $45.67 | $21.9M | 35,525,409 |
| 2009-03-18 | GLAXOSMITHKLINE PLC Director | Sale | −21,101 | $46.40 | $979K | 35,504,308 |
| 2009-03-17 | GLAXOSMITHKLINE PLC Director | Sale | −500,000 | $45.50 | $22.7M | 36,004,308 |
| 2008-09-15 | GLAXOSMITHKLINE PLC 10% owner | Other disposition · Contract to sell | −1 | 0 | ||
| 2008-09-15 | GLAXOSMITHKLINE PLC 10% owner | Other disposition · Contract to sell | −1 | 0 | ||
| 2008-09-15 | GLAXOSMITHKLINE PLC 10% owner | Other disposition · Contract to sell | −1 | 0 | ||
| 2008-09-15 | GLAXOSMITHKLINE PLC 10% owner | Other disposition · Contract to sell | −1 | 0 | ||
| 2008-09-15 | GLAXOSMITHKLINE PLC 10% owner | Other disposition · Contract to sell | −1 | 0 | ||
| 2008-09-15 | GLAXOSMITHKLINE PLC 10% owner | Other disposition · Contract to sell | −1 | 0 |
Page 40 of 42 · 826 trades